COVID-19 IgG/IGM Test

The 2019-NCoV is a large family of viruses known to cause colds as well as more
serious illnesses such as Middle East Respiratory Syndrome (MERS) and Severe
Acute Respiratory Syndrome (SARS). The novel coronavirus is a novel coronavirus
strain that has never been found in humans before.

In more severe cases, the infection can lead to pneumonia, severe acute
respiratory syndrome, kidney failure, and even death.

FRENOVO COVID-19 IgG/IgM rapid test (Whole Blood/ Serum/ Plasma) is a rapid
test that utilizes a combination of COVID-19 antigen-coated colored particles
for the qualitative detection of IgG and IgM antibodies to COVID-19 in human
whole blood, serum, or plasma as an aid in the diagnosis of primary and
secondary COVID-19 infections.
Background of COVID-19 IgG/IGM Test

The 2019-NCoV is a large family of viruses known to cause colds as well as more
serious illnesses such as Middle East Respiratory Syndrome (MERS) and Severe
Acute Respiratory Syndrome (SARS). Novel coronavirus is a novel coronavirus
strain that has never been found in humans before.

In more severe cases, infection can lead to pneumonia, severe acute respiratory
syndrome, kidney failure and even death.

FRENOVO COVID-19 IgG/IgM rapid test (Whole Blood/ Serum/ Plasma) is a rapid
test that utilizes a combination of COVID-19 antigen coated colored particles
for the qualitative detection of IgG and IgM antibodies to COVID-19 in human
whole blood, serum, or plasma as an aid in the diagnosis of primary and
secondary COVID-19 infections.

Principle of COVID-19 IgG/IGM Test
The COVID-19 IgG-IgM Rapid Test (Whole Blood/Serum/Plasma) is a qualitative
membrane-based immunoassay for the detection of IgG and IgM antibodies to 2019-
nCoV in whole blood, serum or plasma specimen. This test consists of two
components, an IgG component and an IgM component. In the IgG component, anti-
human IgG is coated in IgG test line region. During testing, the specimen
reacts with 2019-nCoV antigen-coated particles in the test cassette. The
mixture then migrates upward on the membrane chromatographically by capillary
action and reacts with the anti-human IgG in IgG test line region, if the
specimen contains IgG antibodies to 2019-nCoV.
A colored line will appear in IgG test line region as a result of this.
Similarly, anti-human IgM is coated in IgM test line region and if specimen
contains IgM antibodies to 2019-nCoV, the conjugate-specimen complex reacts
with anti-human IgM. A colored line appears in IgM test line region as a
result.
Therefore, if the specimen contains 2019-nCoV IgG antibodies, a colored line
will appear in IgG test line region. If the specimen contains 2019-nCoV IgM
antibodies, a colored line will appear in IgM test line region. If the specimen
does not contain 2019-nCoV antibodies, no colored line will appear in either of
the test line regions, indicating a negative result. To serve as a procedural
control, a colored line will always appear in the control line region,
indicating that the proper volume of specimen has been added and membrane
wicking has occurred.

As one of the rapid antibody suppliers , we provide self antibody test kit .

As a professional rapid antibody manufacturer, we provide reasonable antibody
rapid test kit price.

More Frenovo products are under development. Strictly following with ISO 13485
quality management system operation with all process, our myo test products are
well accepted by users in domestic and abroad.

Minimum Order: 100 pieces

Click to Enlarge